RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5271
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0305900; Gene model (P.falciparum): PF3D7_0208800; Gene product: protein P22, putative (pb22)
Details mutation: The P. berghei Pb22 gene replaced by the P. vivax Pv22 gene
PhenotypeNo phenotype has been described
Last modified: 29 December 2022, 15:24
  *RMgm-5271
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation
Reference (PubMed-PMID number) Reference 1 (PMID number) : 36503858
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone RMgm-4923
Other information parent lineIn mutant RMgm-4923 the Pb22 gene (open reading frame) is deleted by introducing the hdhfr/yfcu selectable marker cassette
The mutant parasite was generated by
Name PI/ResearcherBai J, Cao Y
Name Group/DepartmentDepartment of Immunology, College of Basic Medical Sciences
Name InstituteChina Medical University
CityShenyang
CountryChina
Name of the mutant parasite
RMgm numberRMgm-5271
Principal nameTrPv22Pb
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
In the mutant the Pb22 gene of P. berghei has been replaced by the Pv22 gene of P. vivax.
The P. vixax Pv22 is introduced in mutant RMgm-4923 in which the Pb22 gene (open reading frame) has been deleted by introducing the hdhfr/yfcu selectable marker cassette. The TrPv22Pb mutant has been selected by negative selection.

Protein (function)
PBANKA_0305900 (Pb22), which is predicted to encode a sexual-stage protein of 218 amino acids (aa) with a molecular weight of 22 kDa. Pb22 has a putative signal peptide (aa 1–18), suggesting that it might be secreted. Pb22 did not contain any domains of known functions.
Analysis of P. berghei mutants lacking Pb22 (
RMgm-4923) showed defects in formation of male gametes (exflagellation), reduced ookinete formation and absence of oocyst formation.

Phenotype
Analysis of P. berghei mutants lacking Pb22 (RMgm-4923) showed defects in formation of male gametes (exflagellation), reduced ookinete formation and absence of oocyst formation.
Analysis of the mutant expressing P. vivax Pv22 showed a normal/wildtype phenotype throughout the complete lifecycle, indicating complementation of the function of Pb22 by Pv22.

Additional information
Pv22 expression was low in early asexual stages but similarly high in schizonts, gametocytes, and ookinetes. Pv22 was expressed in asexual blood stages, localized in the cytosol ring and trophozoite stages, but in schizonts it appeared to be associated with the merozoite surface . In sexual stages, Pv22 was detected in both male and female gametocytes, gametes and ookinetes. Of particular relevance is the peripheral localization of Pv22 in gametes, zygotes and ookinetes.

From the Abstract of the paper:
Since Pv22 in the transgenic parasite showed similar expression and localization patterns to Pb22, we used the TrPv22Pb parasite as a surrogate to evaluate the TB potential of Pv22. In mosquito feeding assays, mosquitoes feeding on rPv22- immunized mice infected with TrPv22Pb parasites showed a 49.3–53.3 % reduction in the oocyst density compared to the control group. In vitro assays showed that the rPv22 immune sera significantly inhibited exflagellation and ookinete formation of the TrPv22Pb parasites.

Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0305900
Gene Model P. falciparum ortholog PF3D7_0208800
Gene productprotein P22, putative
Gene product: Alternative namepb22
Details of the genetic modification
Short description of the mutationThe P. berghei Pb22 gene replaced by the P. vivax Pv22 gene
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedureNo
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modificationIn the mutant the Pb22 gene of P. berghei has been replaced by the Pv22 gene of P. vivax.
The P. vixax Pv22 is introduced in mutant RMgm-4923 in which the Pb22 gene (open reading frame) has been deleted by introducing the hdhfr/yfcu selectable marker cassette. The TrPv22Pb mutant has been selected by negative selection.

To generate a transgenic P. berghei expressing Pv22 with a 3xHA tag referred to as TrPv22Pb, the complete pv22 open reading frame flanked by the 5' and 3' UTR of pb22 was inserted into the pUC57 vector at the HindIII and NotI sites. The plasmid was linearized and electroporated into purified schizonts of mutant RMgm-4923.
Additional remarks selection procedureThe P. vixax Pv22 is introduced in mutant RMgm-4923 in which the Pb22 gene (open reading frame) has been deleted by introducing the hdhfr/yfcu selectable marker cassette. The TrPv22Pb mutant has been selected by negative selection.
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6